nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A4—Temozolomide—brain cancer	0.247	0.387	CbGbCtD
Argatroban—CYP3A4—Lomustine—brain cancer	0.21	0.329	CbGbCtD
Argatroban—CYP3A5—Etoposide—brain cancer	0.13	0.204	CbGbCtD
Argatroban—CYP3A4—Etoposide—brain cancer	0.0507	0.0796	CbGbCtD
Argatroban—F2—vein—brain cancer	0.0265	0.452	CbGeAlD
Argatroban—Gangrene—Hydroxyurea—brain cancer	0.0181	0.0664	CcSEcCtD
Argatroban—F2—endothelium—brain cancer	0.00912	0.155	CbGeAlD
Argatroban—F2—blood vessel—brain cancer	0.00841	0.143	CbGeAlD
Argatroban—Haemorrhage intracranial—Temozolomide—brain cancer	0.00751	0.0276	CcSEcCtD
Argatroban—Haematemesis—Procarbazine—brain cancer	0.00733	0.027	CcSEcCtD
Argatroban—Thrombosis—Procarbazine—brain cancer	0.0072	0.0265	CcSEcCtD
Argatroban—Haemoptysis—Procarbazine—brain cancer	0.00688	0.0253	CcSEcCtD
Argatroban—Pleural effusion—Procarbazine—brain cancer	0.00665	0.0245	CcSEcCtD
Argatroban—Digestion impaired—Hydroxyurea—brain cancer	0.0059	0.0217	CcSEcCtD
Argatroban—Digestion impaired—Temozolomide—brain cancer	0.00461	0.0169	CcSEcCtD
Argatroban—Thrombosis—Carmustine—brain cancer	0.0045	0.0166	CcSEcCtD
Argatroban—Haemoglobin—Lomustine—brain cancer	0.00405	0.0149	CcSEcCtD
Argatroban—Haemorrhage—Lomustine—brain cancer	0.00403	0.0148	CcSEcCtD
Argatroban—Pulmonary oedema—Hydroxyurea—brain cancer	0.00351	0.0129	CcSEcCtD
Argatroban—Infection—Carboplatin—brain cancer	0.00325	0.012	CcSEcCtD
Argatroban—Pulmonary embolism—Carmustine—brain cancer	0.00319	0.0117	CcSEcCtD
Argatroban—Respiratory failure—Temozolomide—brain cancer	0.00314	0.0115	CcSEcCtD
Argatroban—Angina pectoris—Procarbazine—brain cancer	0.00311	0.0114	CcSEcCtD
Argatroban—Renal failure acute—Hydroxyurea—brain cancer	0.0031	0.0114	CcSEcCtD
Argatroban—Pulmonary embolism—Temozolomide—brain cancer	0.00308	0.0113	CcSEcCtD
Argatroban—Dermatitis bullous—Hydroxyurea—brain cancer	0.00299	0.011	CcSEcCtD
Argatroban—F2—Platelet Aggregation (Plug Formation)—MPL—brain cancer	0.00295	0.0911	CbGpPWpGaD
Argatroban—Apnoea—Etoposide—brain cancer	0.00291	0.0107	CcSEcCtD
Argatroban—Pneumonia—Procarbazine—brain cancer	0.00287	0.0105	CcSEcCtD
Argatroban—F2—spinal cord—brain cancer	0.00286	0.0487	CbGeAlD
Argatroban—Infection—Lomustine—brain cancer	0.00284	0.0105	CcSEcCtD
Argatroban—Pain—Carboplatin—brain cancer	0.0028	0.0103	CcSEcCtD
Argatroban—Sepsis—Carmustine—brain cancer	0.00276	0.0102	CcSEcCtD
Argatroban—Haematuria—Procarbazine—brain cancer	0.00272	0.00999	CcSEcCtD
Argatroban—Thrombophlebitis—Carmustine—brain cancer	0.00267	0.00983	CcSEcCtD
Argatroban—Body temperature increased—Carboplatin—brain cancer	0.00259	0.00951	CcSEcCtD
Argatroban—Thrombophlebitis—Temozolomide—brain cancer	0.00258	0.0095	CcSEcCtD
Argatroban—F2—endocrine gland—brain cancer	0.00257	0.0439	CbGeAlD
Argatroban—Haemoglobin—Procarbazine—brain cancer	0.00257	0.00946	CcSEcCtD
Argatroban—Haemorrhage—Procarbazine—brain cancer	0.00256	0.00941	CcSEcCtD
Argatroban—F2—head—brain cancer	0.00254	0.0433	CbGeAlD
Argatroban—F2—central nervous system—brain cancer	0.00232	0.0395	CbGeAlD
Argatroban—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00231	0.00851	CcSEcCtD
Argatroban—Body temperature increased—Lomustine—brain cancer	0.00226	0.00832	CcSEcCtD
Argatroban—Sepsis—Etoposide—brain cancer	0.00214	0.00787	CcSEcCtD
Argatroban—Haemoglobin—Hydroxyurea—brain cancer	0.00199	0.00732	CcSEcCtD
Argatroban—Haemorrhage—Hydroxyurea—brain cancer	0.00198	0.00728	CcSEcCtD
Argatroban—Cough—Procarbazine—brain cancer	0.00194	0.00715	CcSEcCtD
Argatroban—F2—brain—brain cancer	0.00184	0.0314	CbGeAlD
Argatroban—Cardiac failure—Etoposide—brain cancer	0.00183	0.00674	CcSEcCtD
Argatroban—Confusional state—Procarbazine—brain cancer	0.00183	0.00674	CcSEcCtD
Argatroban—Vomiting—Lomustine—brain cancer	0.00182	0.00669	CcSEcCtD
Argatroban—Infection—Procarbazine—brain cancer	0.00181	0.00664	CcSEcCtD
Argatroban—Angiopathy—Hydroxyurea—brain cancer	0.0018	0.00661	CcSEcCtD
Argatroban—Pneumonia—Carmustine—brain cancer	0.00179	0.00659	CcSEcCtD
Argatroban—Tachycardia—Procarbazine—brain cancer	0.00177	0.00652	CcSEcCtD
Argatroban—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.00176	0.0545	CbGpPWpGaD
Argatroban—Urinary tract infection—Carmustine—brain cancer	0.00173	0.00637	CcSEcCtD
Argatroban—Pneumonia—Temozolomide—brain cancer	0.00173	0.00637	CcSEcCtD
Argatroban—Cardiac arrest—Etoposide—brain cancer	0.0017	0.00626	CcSEcCtD
Argatroban—Nausea—Lomustine—brain cancer	0.0017	0.00625	CcSEcCtD
Argatroban—Hypotension—Procarbazine—brain cancer	0.0017	0.00625	CcSEcCtD
Argatroban—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.0017	0.0524	CbGpPWpGaD
Argatroban—Urinary tract infection—Temozolomide—brain cancer	0.00167	0.00616	CcSEcCtD
Argatroban—Haemoglobin—Carmustine—brain cancer	0.00161	0.00592	CcSEcCtD
Argatroban—Haemorrhage—Carmustine—brain cancer	0.0016	0.00589	CcSEcCtD
Argatroban—Haemoglobin—Temozolomide—brain cancer	0.00155	0.00572	CcSEcCtD
Argatroban—Pain—Procarbazine—brain cancer	0.00155	0.00572	CcSEcCtD
Argatroban—Constipation—Procarbazine—brain cancer	0.00155	0.00572	CcSEcCtD
Argatroban—Haemorrhage—Temozolomide—brain cancer	0.00155	0.00569	CcSEcCtD
Argatroban—Feeling abnormal—Procarbazine—brain cancer	0.0015	0.00551	CcSEcCtD
Argatroban—Gastrointestinal pain—Procarbazine—brain cancer	0.00149	0.00547	CcSEcCtD
Argatroban—Body temperature increased—Procarbazine—brain cancer	0.00144	0.00528	CcSEcCtD
Argatroban—Abdominal pain—Procarbazine—brain cancer	0.00144	0.00528	CcSEcCtD
Argatroban—Angiopathy—Temozolomide—brain cancer	0.0014	0.00516	CcSEcCtD
Argatroban—Infection—Hydroxyurea—brain cancer	0.0014	0.00514	CcSEcCtD
Argatroban—Pneumonia—Etoposide—brain cancer	0.00139	0.0051	CcSEcCtD
Argatroban—Acute coronary syndrome—Etoposide—brain cancer	0.00136	0.005	CcSEcCtD
Argatroban—Myocardial infarction—Etoposide—brain cancer	0.00135	0.00497	CcSEcCtD
Argatroban—Back pain—Carmustine—brain cancer	0.00135	0.00496	CcSEcCtD
Argatroban—Hypersensitivity—Procarbazine—brain cancer	0.00134	0.00492	CcSEcCtD
Argatroban—Back pain—Temozolomide—brain cancer	0.0013	0.00479	CcSEcCtD
Argatroban—Dyspnoea—Hydroxyurea—brain cancer	0.00125	0.00461	CcSEcCtD
Argatroban—Diarrhoea—Procarbazine—brain cancer	0.00124	0.00457	CcSEcCtD
Argatroban—Dyspepsia—Hydroxyurea—brain cancer	0.00124	0.00455	CcSEcCtD
Argatroban—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00121	0.00447	CcSEcCtD
Argatroban—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00121	0.0374	CbGpPWpGaD
Argatroban—Pain—Hydroxyurea—brain cancer	0.0012	0.00442	CcSEcCtD
Argatroban—Constipation—Hydroxyurea—brain cancer	0.0012	0.00442	CcSEcCtD
Argatroban—Dizziness—Procarbazine—brain cancer	0.0012	0.00442	CcSEcCtD
Argatroban—Chest pain—Carmustine—brain cancer	0.00119	0.00436	CcSEcCtD
Argatroban—Cough—Temozolomide—brain cancer	0.00117	0.00432	CcSEcCtD
Argatroban—Feeling abnormal—Hydroxyurea—brain cancer	0.00116	0.00426	CcSEcCtD
Argatroban—F2—PAR1-mediated thrombin signaling events—TRPC6—brain cancer	0.00116	0.0357	CbGpPWpGaD
Argatroban—Vomiting—Procarbazine—brain cancer	0.00116	0.00425	CcSEcCtD
Argatroban—Confusional state—Carmustine—brain cancer	0.00115	0.00422	CcSEcCtD
Argatroban—Rash—Procarbazine—brain cancer	0.00115	0.00421	CcSEcCtD
Argatroban—Dermatitis—Procarbazine—brain cancer	0.00114	0.00421	CcSEcCtD
Argatroban—Headache—Procarbazine—brain cancer	0.00114	0.00419	CcSEcCtD
Argatroban—Infection—Carmustine—brain cancer	0.00113	0.00415	CcSEcCtD
Argatroban—Angiopathy—Etoposide—brain cancer	0.00112	0.00413	CcSEcCtD
Argatroban—Body temperature increased—Hydroxyurea—brain cancer	0.00111	0.00409	CcSEcCtD
Argatroban—Tachycardia—Carmustine—brain cancer	0.00111	0.00408	CcSEcCtD
Argatroban—Confusional state—Temozolomide—brain cancer	0.00111	0.00407	CcSEcCtD
Argatroban—Infection—Temozolomide—brain cancer	0.00109	0.00401	CcSEcCtD
Argatroban—Nausea—Procarbazine—brain cancer	0.00108	0.00397	CcSEcCtD
Argatroban—Hypotension—Carmustine—brain cancer	0.00106	0.00391	CcSEcCtD
Argatroban—Back pain—Etoposide—brain cancer	0.00104	0.00383	CcSEcCtD
Argatroban—CYP3A5—endocrine gland—brain cancer	0.00104	0.0178	CbGeAlD
Argatroban—Hypersensitivity—Hydroxyurea—brain cancer	0.00104	0.00381	CcSEcCtD
Argatroban—Dyspnoea—Carmustine—brain cancer	0.00101	0.00373	CcSEcCtD
Argatroban—Gastrointestinal disorder—Carmustine—brain cancer	0.000981	0.00361	CcSEcCtD
Argatroban—Dyspnoea—Temozolomide—brain cancer	0.000979	0.0036	CcSEcCtD
Argatroban—Constipation—Carmustine—brain cancer	0.000972	0.00358	CcSEcCtD
Argatroban—Pain—Carmustine—brain cancer	0.000972	0.00358	CcSEcCtD
Argatroban—Dyspepsia—Temozolomide—brain cancer	0.000967	0.00356	CcSEcCtD
Argatroban—Diarrhoea—Hydroxyurea—brain cancer	0.000962	0.00354	CcSEcCtD
Argatroban—Gastrointestinal disorder—Temozolomide—brain cancer	0.000948	0.00349	CcSEcCtD
Argatroban—Cough—Etoposide—brain cancer	0.00094	0.00346	CcSEcCtD
Argatroban—Constipation—Temozolomide—brain cancer	0.000939	0.00346	CcSEcCtD
Argatroban—Pain—Temozolomide—brain cancer	0.000939	0.00346	CcSEcCtD
Argatroban—Feeling abnormal—Carmustine—brain cancer	0.000937	0.00345	CcSEcCtD
Argatroban—Dizziness—Hydroxyurea—brain cancer	0.00093	0.00342	CcSEcCtD
Argatroban—Gastrointestinal pain—Carmustine—brain cancer	0.00093	0.00342	CcSEcCtD
Argatroban—F2—Regulation of Actin Cytoskeleton—PPP1R12A—brain cancer	0.000927	0.0286	CbGpPWpGaD
Argatroban—Chest pain—Etoposide—brain cancer	0.000917	0.00337	CcSEcCtD
Argatroban—F2—Cell surface interactions at the vascular wall—BSG—brain cancer	0.000906	0.028	CbGpPWpGaD
Argatroban—Feeling abnormal—Temozolomide—brain cancer	0.000905	0.00333	CcSEcCtD
Argatroban—Body temperature increased—Carmustine—brain cancer	0.000899	0.00331	CcSEcCtD
Argatroban—Abdominal pain—Carmustine—brain cancer	0.000899	0.00331	CcSEcCtD
Argatroban—Gastrointestinal pain—Temozolomide—brain cancer	0.000898	0.0033	CcSEcCtD
Argatroban—Vomiting—Hydroxyurea—brain cancer	0.000894	0.00329	CcSEcCtD
Argatroban—Rash—Hydroxyurea—brain cancer	0.000887	0.00326	CcSEcCtD
Argatroban—Confusional state—Etoposide—brain cancer	0.000886	0.00326	CcSEcCtD
Argatroban—Dermatitis—Hydroxyurea—brain cancer	0.000886	0.00326	CcSEcCtD
Argatroban—Headache—Hydroxyurea—brain cancer	0.000881	0.00324	CcSEcCtD
Argatroban—Infection—Etoposide—brain cancer	0.000873	0.00321	CcSEcCtD
Argatroban—Body temperature increased—Temozolomide—brain cancer	0.000868	0.00319	CcSEcCtD
Argatroban—Abdominal pain—Temozolomide—brain cancer	0.000868	0.00319	CcSEcCtD
Argatroban—Tachycardia—Etoposide—brain cancer	0.000858	0.00316	CcSEcCtD
Argatroban—Hypersensitivity—Carmustine—brain cancer	0.000838	0.00308	CcSEcCtD
Argatroban—Nausea—Hydroxyurea—brain cancer	0.000835	0.00307	CcSEcCtD
Argatroban—Hypotension—Etoposide—brain cancer	0.000821	0.00302	CcSEcCtD
Argatroban—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00082	0.0253	CbGpPWpGaD
Argatroban—Hypersensitivity—Temozolomide—brain cancer	0.000809	0.00298	CcSEcCtD
Argatroban—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000789	0.0244	CbGpPWpGaD
Argatroban—Dyspnoea—Etoposide—brain cancer	0.000784	0.00288	CcSEcCtD
Argatroban—CYP3A4—endocrine gland—brain cancer	0.000782	0.0133	CbGeAlD
Argatroban—Diarrhoea—Carmustine—brain cancer	0.000778	0.00286	CcSEcCtD
Argatroban—Gastrointestinal disorder—Etoposide—brain cancer	0.000759	0.00279	CcSEcCtD
Argatroban—Dizziness—Carmustine—brain cancer	0.000752	0.00277	CcSEcCtD
Argatroban—Pain—Etoposide—brain cancer	0.000752	0.00277	CcSEcCtD
Argatroban—Constipation—Etoposide—brain cancer	0.000752	0.00277	CcSEcCtD
Argatroban—Diarrhoea—Temozolomide—brain cancer	0.000752	0.00277	CcSEcCtD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000732	0.0226	CbGpPWpGaD
Argatroban—Dizziness—Temozolomide—brain cancer	0.000726	0.00267	CcSEcCtD
Argatroban—Feeling abnormal—Etoposide—brain cancer	0.000724	0.00266	CcSEcCtD
Argatroban—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000723	0.0223	CbGpPWpGaD
Argatroban—Vomiting—Carmustine—brain cancer	0.000723	0.00266	CcSEcCtD
Argatroban—Gastrointestinal pain—Etoposide—brain cancer	0.000719	0.00264	CcSEcCtD
Argatroban—Rash—Carmustine—brain cancer	0.000717	0.00264	CcSEcCtD
Argatroban—Dermatitis—Carmustine—brain cancer	0.000716	0.00263	CcSEcCtD
Argatroban—Headache—Carmustine—brain cancer	0.000712	0.00262	CcSEcCtD
Argatroban—F2—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000705	0.0218	CbGpPWpGaD
Argatroban—CYP3A4—central nervous system—brain cancer	0.000704	0.012	CbGeAlD
Argatroban—Vomiting—Temozolomide—brain cancer	0.000698	0.00257	CcSEcCtD
Argatroban—Abdominal pain—Etoposide—brain cancer	0.000695	0.00256	CcSEcCtD
Argatroban—Body temperature increased—Etoposide—brain cancer	0.000695	0.00256	CcSEcCtD
Argatroban—Rash—Temozolomide—brain cancer	0.000693	0.00255	CcSEcCtD
Argatroban—Dermatitis—Temozolomide—brain cancer	0.000692	0.00255	CcSEcCtD
Argatroban—Headache—Temozolomide—brain cancer	0.000688	0.00253	CcSEcCtD
Argatroban—Nausea—Carmustine—brain cancer	0.000675	0.00248	CcSEcCtD
Argatroban—Nausea—Temozolomide—brain cancer	0.000653	0.0024	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—SOD2—brain cancer	0.000649	0.0201	CbGpPWpGaD
Argatroban—Hypersensitivity—Etoposide—brain cancer	0.000648	0.00238	CcSEcCtD
Argatroban—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000622	0.0192	CbGpPWpGaD
Argatroban—Diarrhoea—Etoposide—brain cancer	0.000601	0.00221	CcSEcCtD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000594	0.0184	CbGpPWpGaD
Argatroban—Dizziness—Etoposide—brain cancer	0.000581	0.00214	CcSEcCtD
Argatroban—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000563	0.0174	CbGpPWpGaD
Argatroban—Vomiting—Etoposide—brain cancer	0.000559	0.00206	CcSEcCtD
Argatroban—Rash—Etoposide—brain cancer	0.000554	0.00204	CcSEcCtD
Argatroban—Dermatitis—Etoposide—brain cancer	0.000554	0.00204	CcSEcCtD
Argatroban—Headache—Etoposide—brain cancer	0.000551	0.00203	CcSEcCtD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000536	0.0166	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—SOD2—brain cancer	0.000528	0.0163	CbGpPWpGaD
Argatroban—Nausea—Etoposide—brain cancer	0.000522	0.00192	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—SOD2—brain cancer	0.000419	0.013	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—RELA—brain cancer	0.000381	0.0118	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—RELA—brain cancer	0.000375	0.0116	CbGpPWpGaD
Argatroban—F2—Hemostasis—MPL—brain cancer	0.000363	0.0112	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—PTCH2—brain cancer	0.000362	0.0112	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—TRPC6—brain cancer	0.000357	0.011	CbGpPWpGaD
Argatroban—F2—Hemostasis—S100A10—brain cancer	0.000348	0.0108	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000341	0.0105	CbGpPWpGaD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000336	0.0104	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—VAV1—brain cancer	0.000321	0.00991	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000319	0.00986	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—OR4C12—brain cancer	0.000318	0.00982	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—OR14C36—brain cancer	0.000318	0.00982	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000315	0.00975	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000312	0.00965	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000311	0.00961	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—RELA—brain cancer	0.000305	0.00943	CbGpPWpGaD
Argatroban—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000289	0.00894	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—OR4C12—brain cancer	0.000289	0.00892	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—OR14C36—brain cancer	0.000289	0.00892	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000276	0.00853	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL2—brain cancer	0.000275	0.00849	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	0.000263	0.00812	CbGpPWpGaD
Argatroban—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000257	0.00793	CbGpPWpGaD
Argatroban—F2—Hemostasis—BSG—brain cancer	0.000246	0.00759	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—RELA—brain cancer	0.000242	0.00749	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000234	0.00723	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	0.000204	0.00629	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—APC—brain cancer	0.000204	0.00629	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—SHH—brain cancer	0.000187	0.00577	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PTCH2—brain cancer	0.000186	0.00575	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—SMO—brain cancer	0.000177	0.00547	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—PTCH1—brain cancer	0.000177	0.00547	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TP53—brain cancer	0.000176	0.00546	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—OR14C36—brain cancer	0.00017	0.00527	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—OR4C12—brain cancer	0.00017	0.00527	CbGpPWpGaD
Argatroban—F2—Hemostasis—TRPC6—brain cancer	0.000161	0.00497	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—ABR—brain cancer	0.000161	0.00497	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.000149	0.00459	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000147	0.00453	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—ABR—brain cancer	0.000146	0.00451	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—DTX2—brain cancer	0.000145	0.00448	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000145	0.00447	CbGpPWpGaD
Argatroban—F2—Hemostasis—VAV1—brain cancer	0.000121	0.00373	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTCH2—brain cancer	0.00011	0.00339	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—EGFR—brain cancer	0.00011	0.00339	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HES5—brain cancer	0.000106	0.00329	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—IL2—brain cancer	0.000105	0.00323	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STRADA—brain cancer	0.000103	0.00319	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—TRPC6—brain cancer	0.000102	0.00314	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—SHH—brain cancer	9.58e-05	0.00296	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—TRPC6—brain cancer	9.24e-05	0.00285	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PTCH1—brain cancer	9.08e-05	0.00281	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—SMO—brain cancer	9.08e-05	0.00281	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—VEGFA—brain cancer	8.88e-05	0.00275	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ABR—brain cancer	8.62e-05	0.00266	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GLI2—brain cancer	8.32e-05	0.00257	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	8.17e-05	0.00253	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GLI1—brain cancer	7.83e-05	0.00242	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CG—brain cancer	7.66e-05	0.00237	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—VAV1—brain cancer	7.62e-05	0.00236	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SUFU—brain cancer	7.42e-05	0.00229	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GFAP—brain cancer	7.16e-05	0.00221	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—VAV1—brain cancer	6.92e-05	0.00214	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HEY1—brain cancer	6.79e-05	0.0021	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—DLL1—brain cancer	6.65e-05	0.00206	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SHH—brain cancer	5.66e-05	0.00175	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TRPC6—brain cancer	5.46e-05	0.00169	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP2C9—brain cancer	5.39e-05	0.00167	CbGpPWpGaD
Argatroban—F2—Hemostasis—IL2—brain cancer	5.39e-05	0.00167	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTCH1—brain cancer	5.36e-05	0.00166	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SMO—brain cancer	5.36e-05	0.00166	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CG—brain cancer	4.84e-05	0.0015	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—BSG—brain cancer	4.59e-05	0.00142	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—brain cancer	4.58e-05	0.00142	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CG—brain cancer	4.39e-05	0.00136	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOTCH2—brain cancer	4.29e-05	0.00133	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CTNNB1—brain cancer	4.09e-05	0.00126	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VAV1—brain cancer	4.09e-05	0.00126	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—IDH1—brain cancer	3.94e-05	0.00122	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HES1—brain cancer	3.52e-05	0.00109	CbGpPWpGaD
Argatroban—F2—Hemostasis—TP53—brain cancer	3.46e-05	0.00107	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—IL2—brain cancer	3.4e-05	0.00105	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PDGFRA—brain cancer	3.35e-05	0.00103	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SPP1—brain cancer	3.25e-05	0.001	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ENO2—brain cancer	3.12e-05	0.000964	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL2—brain cancer	3.09e-05	0.000956	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IRS2—brain cancer	2.94e-05	0.000908	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APC—brain cancer	2.6e-05	0.000802	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CG—brain cancer	2.6e-05	0.000802	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP2C9—brain cancer	2.51e-05	0.000775	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EGFR—brain cancer	2.36e-05	0.000731	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—BSG—brain cancer	2.13e-05	0.000659	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RELA—brain cancer	2.03e-05	0.000627	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ERBB2—brain cancer	2.02e-05	0.000623	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—IDH1—brain cancer	1.83e-05	0.000567	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL2—brain cancer	1.83e-05	0.000565	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCND1—brain cancer	1.78e-05	0.00055	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CTNNB1—brain cancer	1.76e-05	0.000545	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—brain cancer	1.55e-05	0.00048	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT3—brain cancer	1.54e-05	0.000475	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ENO2—brain cancer	1.45e-05	0.000448	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CG—brain cancer	1.43e-05	0.000442	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MYC—brain cancer	1.43e-05	0.000441	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EGFR—brain cancer	1.4e-05	0.000432	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TP53—brain cancer	1.17e-05	0.000363	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CG—brain cancer	6.65e-06	0.000206	CbGpPWpGaD
